Divalproex Sodium
- Product NDC
- 68382-031
- 11-digit product format
- 683820031
- Labeler code
- 68382
- Product ID
- 68382-031_2ff00ecb-deca-4c29-823b-6e76890b2869
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Divalproex Sodium
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Application
- ANDA077100
- Marketing category
- ANDA
- Marketing start
- 2010-03-06
- Marketing end
- 0000-00-00
- Substance
- DIVALPROEX SODIUM
- Active strength
- 125 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68382-031-01 | 68382003101 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-031-01) | 2010-03-06 | 0000-00-00 | No | No | Current |
| 68382-031-05 | 68382003105 | 500 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-031-05) | 2010-03-06 | 0000-00-00 | No | No | Current |